AstraZeneca Voluntarily Withdraws Imfinzi Indication in Locally Advanced or Metastatic Bladder Cancer
AstraZeneca has voluntarily withdrawn durvalumab’s (Imfinzi’s) indication for adults with locally advanced or metastatic bladder cancer.
All articles by Cancer Therapy Advisor Staff
Clinical Trial: LOXO-305 Faces Off Against FDA-Approved Covalent BTK Inhibitors
Loxo Oncology is preparing to initiate the global, randomized, BRUIN MCL-321 superiority study in patients with Bruton tyrosine kinase inhibitor-naïve disease.
The 62nd ASH Annual Meeting and Exposition: What to Expect
The plenary program will include talks on sickle cell disease, hematologic malignancies, resistance mechanisms, and treatment disparities.
Clinical Trial: Combination of Letrozole Plus Abemaciclib in Estrogen Receptor–Positive Endometrial Cancer
Does abemaciclib and letrozole effective slow or stop endometrial cancer cell growth?
Clinical Trial: Mirvetuximab Soravtansine and Pembrolizumab in Endometrial Cancer
All patients will receive mirvetuximab soravtansine and pembrolizumab in this study.
Trial to Evaluate PORTEC-4a: Molecular Profile-Based vs Standard Adjuvant Radiotherapy in Endometrial Cancer
A phase 3 study seeks to evaluate the value of selecting therapy based on molecular profiling.
Clinical Trial: Phase 3 AtTEnd Trial in Endometrial Cancer
Patients with advanced or recurrent endometrial cancer enrolled in the experimental arm will receive atezolizumab in combination with paclitaxel and carboplatin.
Clinical Trial: Evaluating Bioactivity in Breast Cancer Tumor Tissue After Intratumoral Administration of PVSRIPO
The objective of the study is to investigate PVSRIPO-mediated inflammation and immunity in women invasive breast cancer.
Trial Aims to Increase Breast Cancer Screening Rates in African Immigrants Living in the United States
Barriers to breast cancer screening for certain minority groups have been studied, but less is known about the barriers for African immigrant women.
Trial to Evaluate Safety and Efficacy After Omission of Sentinel Node Biopsy in Estrogen-Positive Breast Cancer
Enrolled patients will undergo standard of care lumpectomy without sentinel node biopsy followed by radiation and hormonal therapy.
-
Loading...
-
Loading...
